announces

Orqa Announces Global Manufacturing Program to Expand Drone Production to 1 Million Units Annually

OSIJEK, Croatia, Dec. 23, 2025 /PRNewswire/ -- Orqa, Europe's leading developer of FPV (first-person view) and unmanned aerial systems (UAS),…

5 months ago

Curium Announces First Commercial Doses of PYLCLARI for Patients with Prostate Cancer in Poland

PYLCLARI® provides solutions to a wider patient group across Poland where there is high demand and unmet need PARIS, Dec.…

5 months ago

DataGavel Announces Full Acquisition by Renvent Holdings as Platform Emerges as the Defense Bars Advantage

ROSWELL, Ga., Dec. 22, 2025 (GLOBE NEWSWIRE) -- DataGavel, the LegalTech platform built to give defendants a faster, data-driven edge…

5 months ago

Mawson Infrastructure Group Inc. Announces Compliance with Nasdaq Continued Listing Requirements

December 22, 2025 14:05 ET  | Source: Mawson Infrastructure Group Inc. MIDLAND, Pa., Dec. 22, 2025 (GLOBE NEWSWIRE) -- Mawson…

5 months ago

SOS Limited Announces Development of Tier III Modular Data Center at Longfellow Ranch, Texas

NEW YORK, Dec. 22, 2025 /PRNewswire/ -- SOS Limited (NYSE: SOS) ("SOS" or the "Company") announced today that it is…

5 months ago

Velo Announces Integration of USD1 With World Liberty Financial to Strengthen PayFi Infrastructure Across Asia

SINGAPORE, Dec. 22, 2025 /PRNewswire/ -- Velo, a PayFi infrastructure protocol focused on real world financial adoption, today announced a strategic…

5 months ago

Bitmine Immersion (BMNR) Announces ETH Holdings Reach 4.066 Million Tokens, and Total Crypto and Total Cash Holdings of $13.2 Billion

Bitmine now owns 3.37% of the ETH token supply, two-thirds of the way to the 'Alchemy of 5%'Bitmine Crypto +…

5 months ago

Biosplice Therapeutics Announces First Patient Dosed in InvestigatorInitiated Phase 1 Clinical Trial of Cirtuvivint and Olaparib in BRCA/HRD PlatinumResistant Ovarian Cancer

SAN DIEGO, Dec. 22, 2025 (GLOBE NEWSWIRE) -- Biosplice Therapeutics, Inc. (“Biosplice”), a clinical-stage biotechnology company advancing small-molecule inhibition of…

5 months ago

Alvotech announces European launch of first-in-market biosimilar to Simponi (golimumab) globally by partner Advanz Pharma

Introduction of AVT05 supported by NHS England tender award in the United Kingdom REYKJAVIK, Iceland, Dec. 22, 2025 (GLOBE NEWSWIRE)…

5 months ago